Annual Meeting

Stressed out? The cancer playbook may help

Learn about the session on stress adaptations in tumor progression in the Maximizing Access Committee’s symposium at Discover BMB 2024
Jonathan A. Kelber
By Jonathan A. Kelber
Sept. 14, 2023

We often associate the concept of stress with deadlines, emergencies, traffic or hardships. For those who study biological and biochemical processes of disease in cell and organismal models, the idea of stress adaptation is recognized as one mechanism by which malignant and nonmalignant cells survive and thrive within environments that, at times, are hostile.

Are there ways that we think about environmental stress adaptations at an organismal level that may help scientists develop new perspectives on combatting cancer to improve patient outcomes? Indeed, cancer cells may even engage in molecular decision-making activities that differentiate between fight-or-flight responses in the face of environmental stress.

Submit an abstract

Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30. See the categories.

This session will consider the mechanisms by which cancer cells adapt to intrinsic and extrinsic stressors and how defining these adaptative mechanisms may lead to improved treatment strategies. Topics will include nutrient access/use, aging, subcellular compartments, microenvironmental influences and tissue reprogramming.

Keywords: Cancer biology, molecular crosstalk, biochemical signaling, tissue homeostasis, aging, subcellular transport, local and global adaptations, tumor microenvironment.

Who should attend: Cancer researchers, cell biologists and biochemists interested in considering how aging, biochemistry and multi-scale adaptations cooperate to shape the stress landscapes of tumors.

Theme song: “Stressed Out” by A Tribe Called Quest

This session is powered by cortisol and catecholamines.

Stress adaptations in tumor progression

Jonathan Kelber (chair), Baylor University

Elda GrabockaThomas Jefferson University

Christina TowersSalk Institute for Biological Studies

Mark LaBargeBeckman Research Institute of City of Hope

 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Jonathan A. Kelber
Jonathan A. Kelber

Jonathan A. Kelber is an associate professor of biology at Baylor University.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Protein modifications drive lung cancer resistance
Journal News

Protein modifications drive lung cancer resistance

Nov. 6, 2025

New assay enriches protein modifications in a single process, enabling detection of key changes in drug-resistant lung cancer cells that may guide future therapies.

How antigen-processing proteins shape immunity
Journal News

How antigen-processing proteins shape immunity

Nov. 6, 2025

Researchers show how components of the antigen processing machinery shape the immunopeptidome, offering insights into immune regulation and cancer biology.

New chemical strategy boosts accuracy in proteomics
Journal News

New chemical strategy boosts accuracy in proteomics

Nov. 6, 2025

Researchers develop a methylamine-based method that nearly eliminates peptide overlabeling in proteomics, improving accuracy in protein identification and quantitation.

Understanding the roles of extracellular matrix and vesicles in valvular disease
Profile

Understanding the roles of extracellular matrix and vesicles in valvular disease

Oct. 30, 2025

MOSAIC scholar Cassandra Clift uses mass spectrometry and multiomics to study cardiovascular calcification and collagen dysregulation, bridging her background in bioengineering and biology to investigate extracellular vesicles and heart disease.

Lipid profiles reveal sex differences in type 2 diabetes
Journal News

Lipid profiles reveal sex differences in type 2 diabetes

Oct. 29, 2025

Researchers explored the lipid profiles of individuals with type 2 diabetes and identified potentially useful lipid biomarkers for this condition.

Serum lipids may predict early diabetes risk
Journal News

Serum lipids may predict early diabetes risk

Oct. 29, 2025

Researchers found that levels of two key fatty acids may predict worsening tolerance for glucose, independent of body fat and insulin levels. In turn, these fatty acids may serve as early T2D biomarkers.